SBRT 2016

MESSAGE TO TAKE HOME

• SBRT offers high local control in selected patients with primary liver tumors

• SBRT can be delivered as a definitive treatment but also as a pre-transplant therapy

• Toxicity is acceptable in most studies, however patients with advanced cirrhosis have a higher risk of toxicity

• Randomized trials are needed to define the role of SBRT in the treatment of primary liver tumors